RESEARCH-USE BIOSIMILAR ANTIBODY
Selicrelumab
Monoclonal antibody · IgG2
Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study.
TARGETTNFRSF5
YMonoclonal antibody
CATALOGSC-BS-190
CATALOG NUMBERSC-BS-190
MOLECULAR WEIGHTApprox. 146.2 kDa
PRODUCT FORMATMonoclonal antibody
PRODUCT OVERVIEW
A research-use configuration for comparative antibody studies
Selicrelumab is an agonist CD40 antibody, induces changes in the tumor microenvironment. Selicrelumab can be used for the research of pancreatic cance and neoadjuvant study.
Selicrelumab is a recombinant research-use antibody directed against TNFRSF5.